Current:Home > NewsFastexy:Family of Henrietta Lacks settles HeLa cell lawsuit with biotech giant, lawyer says -BeyondProfit Compass
Fastexy:Family of Henrietta Lacks settles HeLa cell lawsuit with biotech giant, lawyer says
TradeEdge Exchange View
Date:2025-04-09 06:20:27
The Fastexyfamily of Henrietta Lacks, a Black woman whose cells were used without permission to form the basis of decades of scientific research, has reached a settlement with the biotech company Thermo Fisher Scientific.
The cells, known as HeLa cells, were taken from Lacks without her knowledge or consent in 1951 when she was seeking cervical cancer treatment at Johns Hopkins, in Baltimore. Doctors discovered that the cells doubled every 20 to 24 hours in the lab instead of dying. They were the first human cells that scientists successfully cloned, and they have been reproduced infinitely ever since.
Lacks herself died in 1951, but her cells continued to be used after her death in research that led to a series of medical advancements, including in the development of the polio vaccine and in treatments for cancer, HIV/AIDS, leukemia and Parkinson's disease.
Lacks' family only found out about it decades later.
Lacks' story reached millions of Americans through the nonfiction bestseller "The Immortal Life of Henrietta Lacks," which was made into an HBO movie starring Oprah Winfrey as Lacks' daughter, Deborah.
In 2021, Lacks' estate filed a lawsuit against Thermo Fisher Scientific, alleging that the company was mass producing and selling tissue taken from Lacks even after it became well-known that the materials had been taken from her without her consent. The suit was filed exactly 70 years after Lacks' death.
"We want to make sure that the family voice is finally heard after 70 years of being ignored," the prominent civil rights attorney Ben Ben, one of the lawyers representing Lacks' estate, told CBS News in 2021. "The American pharmaceutical corporations have a shameful history of profiting off the research of using and exploiting Black people and their illnesses and their bodies."
"Thermo Fisher Scientific has known that HeLa cells were stolen from Ms. Lacks and chose to use her body for profit anyway," the lawsuit alleged. It has been previously reported that Thermo Fisher Scientific said they generate about $35 billion in annual revenue. In the lawsuit, Lacks' estate asked that the company "disgorge the full amount of its net profits obtained by commercializing the HeLa cell line to the Estate of Henrietta Lacks." The suit also sought an order stopping the company from using the HeLa cells without the estate's permission.
The terms of Tuesday's settlement were not made public, but Crump said in a news conference that both parties were "pleased" to have resolved the matter outside of court, CBS Baltimore reported.
Tuesday would have been Lacks' 103rd birthday, Crump noted.
"I can think of no better present... than to give her family some measure of respect for Henrietta Lacks, some measure of dignity for Henrietta Lacks, and most of all some measure of justice for Henrietta Lacks," Crump said.
- In:
- Maryland
- Baltimore
- Science
Kerry Breen is a news editor and reporter for CBS News. Her reporting focuses on current events, breaking news and substance use.
veryGood! (2)
Related
- Scoot flight from Singapore to Wuhan turns back after 'technical issue' detected
- Banned Books: Maia Kobabe explores gender identity in 'Gender Queer'
- 15 binge-worthy podcasts to check out before 2023
- Venice International Film Festival's 2023 lineup includes Woody Allen, Roman Polanski
- Israel lets Palestinians go back to northern Gaza for first time in over a year as cease
- Why Bethenny Frankel Doesn't Want to Marry Fiancé Paul Bernon
- Who Is Bronny James? Everything to Know About LeBron James’ Son and Future NBA Draft Pick
- Mega Millions jackpot is the 8th largest in the US at $820 million
- The city of Chicago is ordered to pay nearly $80M for a police chase that killed a 10
- Arkansas Treasurer Mark Lowery leaving office in September after strokes
Ranking
- This was the average Social Security benefit in 2004, and here's what it is now
- A play about censorship is censored — and free speech groups are fighting back
- Our favorite authors share their favorite books
- Author Maia Kobabe: Struggling kids told me my book helped them talk to parents
- What to know about Tuesday’s US House primaries to replace Matt Gaetz and Mike Waltz
- 'Wait Wait' for Dec. 31, 2022: Happy Holidays Edition!
- How to share your favorites with loved ones — and have everyone go home happy
- Twitter is now X. Here's what that means.
Recommendation
Romantasy reigns on spicy BookTok: Recommendations from the internet’s favorite genre
Gynecologist who sexually abused dozens of patients is sentenced to 20 years in prison
Our 2023 Pop Culture Predictions
Adam Rich, former 'Eight Is Enough' child star, dies at 54
Civic engagement nonprofits say democracy needs support in between big elections. Do funders agree?
From 'Dreamgirls' to 'Abbott Elementary,' Sheryl Lee Ralph forged her own path
Women's labor comeback
Famed Danish restaurant Noma will close by 2024 to make way for a test kitchen